Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Associated Press (12.26.07) - Wednesday, December 26, 2007
Tom Hester Jr.
"We can significantly reduce the number of infections to newborns and help break down the stigma associated with the disease," said Codey, the Essex County Democrat who is acting governor while Gov. Jon S. Corzine is out of the country for the holidays. "For newborns, early detection can be the ultimate lifesaving measure."
Currently, the state only requires pregnant women be offered HIV testing. Under the new measure, which Codey sponsored while Senate president, pregnant women will be tested for HIV unless they specifically decline. Doctors will provide pregnant patients with information about HIV/AIDS, the benefits of testing, and data about how much the risk of mother-to-child HIV transmission is reduced if an infected mother receives treatment. Newborns will be tested for HIV if the mother is positive or if her status is unknown.
Medical intervention during pregnancy can cut the risk of mother-to-child HIV transmission from 25 percent to 2 percent, according to CDC.
New Jersey has about 115,000 births per year, and it had seven infants born with HIV in 2005, state health figures show.
The American Civil Liberties Union and some women's groups contend the testing measure deprives women the authority to make medical decisions. "Women's privacy rights and choices are as constitutionally valid as any other citizen, regardless of reproductive status," said Maretta J. Short, New Jersey's president of the National Organization for Women.
"Early detection and treatment are integral parts of the fight against HIV and AIDS," said Assembly member John McKeon (D- Essex). "Preventive measures like this can save lives and improve the quality of life for newborns and mothers."
The law will take effect in six months.
071226
AD072672
Copyright © 2007 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.